Clinical Trials Browser

Unknown × Stomach Neoplasms × spartalizumab × Clear all

NCT05468138 2022-08-26

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms